Cite
de Muijnck C, van Gorkom Y, van Duijvenvoorde M, et al. Evaluation of EphB4 as Target for Image-Guided Surgery of Breast Cancer. Pharmaceuticals (Basel). 2020;13(8)doi: 10.3390/ph13080172.
de Muijnck, C., van Gorkom, Y., van Duijvenvoorde, M., Eghtesadi, M., Dekker-Ensink, G., Bhairosingh, S. S., Affinito, A., Kuppen, P. J. K., Vahrmeijer, A. L., & Sier, C. F. M. (2020). Evaluation of EphB4 as Target for Image-Guided Surgery of Breast Cancer. Pharmaceuticals (Basel, Switzerland), 13(8), . https://doi.org/10.3390/ph13080172
de Muijnck, Cansu, et al. "Evaluation of EphB4 as Target for Image-Guided Surgery of Breast Cancer." Pharmaceuticals (Basel, Switzerland) vol. 13,8 (2020). doi: https://doi.org/10.3390/ph13080172
de Muijnck C, van Gorkom Y, van Duijvenvoorde M, Eghtesadi M, Dekker-Ensink G, Bhairosingh SS, Affinito A, Kuppen PJK, Vahrmeijer AL, Sier CFM. Evaluation of EphB4 as Target for Image-Guided Surgery of Breast Cancer. Pharmaceuticals (Basel). 2020 Jul 30;13(8). doi: 10.3390/ph13080172. PMID: 32751634; PMCID: PMC7464973.
Copy
Download .nbib